Full-Time
Analyzes medical data for improved diagnosis
$60k - $65k/yr
Mid
Remote in USA
Remote
This role is fully remote within the US.
SmarterDx simplifies medical diagnosis by analyzing extensive patient data, including notes, lab results, and vital signs. Its main service uses counterfactual modeling to identify missed opportunities in Clinical Documentation Improvement (CDI) and coding, helping healthcare providers enhance patient care and boost revenue. Unlike competitors, SmarterDx offers a risk-free business model with a guaranteed 5:1 return on investment, ensuring clients see significant financial benefits. The goal of SmarterDx is to transform slow, manual diagnosis processes into quick, informed decisions, ultimately improving patient outcomes and increasing healthcare provider efficiency.
Company Size
51-200
Company Stage
Series B
Total Funding
$56M
Headquarters
New York City, New York
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Free One Medical membership
Parental Leave
Remote Work Options
Every day, someone dies from getting the wrong medication or improper dosages of the right one. Now, researchers at the University of Washington (UW) are working on ways to solve this problem in part by using artificial intelligence (AI), NBC News reported Sunday (May 25). Dr. Kelly Michaelsen, an assistant professor of anesthesiology and pain medicine, told the network she had read studies at the prevalence of medication errors among anesthesiologists and began to wonder if AI could help spot errors
Prestigious international annual awards program recognizes standout digital health and medical technology products and companies.NEW YORK, May 8, 2025 /PRNewswire/ -- SmarterDx, the leader in clinical AI for revenue integrity and care quality, announced today that it has been selected as winner of the "Best Overall Healthcare Operations Solution" award in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market
New Mountain Capital has made a strategic investment in SmarterDx, a New York-based company specializing in clinical AI for revenue integrity and care quality. New Mountain, also based in New York, is a growth-focused investment firm managing approximately $55 billion in assets. The terms of the investment were not disclosed.
SmarterDx, a NYC-based clinical AI company, received an undisclosed investment from New Mountain Capital. The funds will support growth and product innovation. Founded in 2020, SmarterDx provides a platform to help hospitals analyze discharges and improve revenue integrity. Its solutions, SmarterPrebill™ and SmarterDenials™, assist in recovering revenue and improving care quality. Over 40 health systems with 180 hospital sites use its platform.
SmarterDx, Inc., a leader in clinical AI for revenue integrity and care quality, announced a strategic investment from New Mountain Capital, LLC, a leading growth-oriented investment firm with more than $55 billion in assets under management.